Latest filing published 22 Sept 2026 for Myriad Genetics INC, €8,919.
Benjamin Richard Wheeler discloses dealings in Myriad Genetics Inc to SEC (Form 4). We count 12 filings; the first trade dates from 16 August 2025 and the latest from 21 September 2026.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 22 September 2026, reports a share grant of €8,919 in Myriad Genetics Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations